First Mercantile Trust’s United Therapeutics UTHR Stock Holding History

First Mercantile Trust’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$124K	Sell	670 -46	-6%	-$9.06K	0.02%	585
2021 Q2	$128K	Buy	716 +150	+27%	+$28.6K	0.02%	608
2021 Q1	$95K	Sell	566 -25	-4%	-$4.17K	0.01%	694
2020 Q4	$90K	Sell	591 -48	-8%	-$6.3K	0.01%	711
2020 Q3	$87K	Sell	639 -99	-13%	-$10.9K	0.01%	709
2020 Q2	$89K	Sell	738 -21	-3%	-$2.36K	0.01%	710
2020 Q1	$72K	Buy	+759	New	+$72.1K	0.01%	634
2019 Q4	–	Sell	-240	Closed	-$19K	–	906
2019 Q3	$19K	Buy	240 +10	+4%	+$805	﹤0.01%	887
2019 Q2	$18K	Sell	230 -60	-21%	-$5.61K	﹤0.01%	828
2019 Q1	$34K	Sell	290 -50	-15%	-$5.83K	0.01%	804
2018 Q4	$37K	Buy	340 +110	+48%	+$12.8K	0.01%	812
2018 Q3	$29K	Hold	230	–	–	0.01%	833
2018 Q2	$26K	Buy	+230	New	+$25.3K	0.01%	868

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Mercantile Trust's UTHR Position: Q3 2021 in Review

First Mercantile Trust reduced its United Therapeutics (UTHR) stake by 6.4% in Q3 2021, selling an estimated $9.06K and leaving 670 shares worth $124K. The position accounts for 0.02% of the portfolio, ranked #585.

First Mercantile Trust first reported a position in UTHR in Q2 2018 and has held it in 13 quarters since. The position peaked at $128K in Q2 2021. 426 funds tracked by Wall St. Rank hold UTHR as of Q3 2021.

First Mercantile Trust held 670 shares of United Therapeutics worth $124K as of Q3 2021.
First Mercantile Trust sold 46 United Therapeutics shares in Q3 2021, an estimated $9.06K.
United Therapeutics made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #585 holding.
First Mercantile Trust first reported a position in United Therapeutics in Q2 2018 and has held it in 13 quarters since.
First Mercantile Trust's United Therapeutics position peaked at $128K in Q2 2021.
426 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.